Enumeral Biomedical Holdings, Inc.
Pharmaceutical company · Arlington, Massachusetts, United States
Enumeral Biomedical Holdings, Inc. is a pharmaceutical company headquartered in Arlington, Massachusetts, United States. Its earliest recorded incorporation is in 2012. It has reported private securities offerings to the US SEC, most recently $668,000 sold in a notice filed in 2017.
Enumeral Biomedical Holdings at a glance
What does Enumeral Biomedical Holdings do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $668,000 sold (2017).
Frequently asked questions about Enumeral Biomedical Holdings
Where is Enumeral Biomedical Holdings headquartered?
Enumeral Biomedical Holdings, Inc. is headquartered in Arlington, Massachusetts, United States.
What does Enumeral Biomedical Holdings do?
Enumeral Biomedical Holdings, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Enumeral Biomedical Holdings founded?
The earliest incorporation on record for Enumeral Biomedical Holdings, Inc. is in 2012, according to public company registers.
Similar companies
- KALA BIO, Inc.Arlington, Massachusetts, United States
- Sojournix, Inc.Arlington, Massachusetts, United States
- Revere Pharmaceuticals Inc.Arlington, Massachusetts, United States
- Sentonix, Inc.Arlington, Massachusetts, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences